CLAPHAM PARK GROUP PRACTICE
72 CLARENCE AVENUE, LONDON
CKD 4
The percentage of patients on the CKD register with hypertension who are treated with an angiotensin coverting enzyme inhibitor (ACE-I) or angiotensin receptor blocker (AEB) (unless a contraindication or side effects are recorded)
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| CKD 4 | 2007 | 47 | 59 | 79.7% | |
| CKD 4 | 2008 | 132 | 163 | 81.0% | |
| CKD 5 | 2009 | 26 | 33 | 78.8% | |
| CKD 5 | 2010 | 18 | 21 | 85.7% | |
| CKD 5 | 2011 | 18 | 23 | 78.3% | |
| CKD 5 | 2012 | 20 | 25 | 80.0% | |
| CKD 5 | 2013 | 20 | 25 | 80.0% | |
| CKD003 | 2014 | 18 | 21 | 85.7% | |
| CKD003 | 2015 | 16 | 18 | 88.9% | |
| NM84 | 2016 | 13 | 18 | 72.2% | |
| NM84 | 2017 | 12 | 17 | 70.6% | |
| NM84 | 2018 | 13 | 16 | 81.2% | |
| NM84 | 2020 | 12 | 19 | 63.2% | |
| NM84 | 2022 | 11 | 18 | 61.1% | |
| NM84 | 2023 | 10 | 16 | 62.5% |
